Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, looking exclusively at women.
Medtronic’s Evolut valve reduces dysfunction, improves quality of life in women with severe aortic stenos
- Thread starter Educator
- Start date